Is Google-Backed Telemedicine Stock Amwell a Buy After Its IPO?
The year 2020 has been a big one for telemedicine. The ability to visit with a healthcare provider via the phone or online video conferencing has been around for awhile, but usage of such services had been modest. COVID-19 changed all of that. Amidst the crisis, Google-backed telemedicine upstart American Well (NYSE: AMWL) has been making hay.
Amwell differs from telemedicine's early leader, Teladoc Health (NYSE: TDOC), which is merging with Livongo Health (NASDAQ: LVGO) in a blockbuster deal to widen its lead in providing patients remote visits with a healthcare professional. Amwell, meanwhile, has moved upmarket and built a platform that healthcare providers can make use of, rather than employing those specialists directly.
Image source: Getty Images.
Source Fool.com
